Prognostic markers in resectable non-small cell lung cancer

Hematology/Oncology Clinics of North America

Volumn 11, Issue 3, 1997, Pages 409-434

  Strauss, G M ^a  

^a UMASS MEMORIAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STAGING; CANCER SURVIVAL; GENETIC MARKER; HUMAN; LUNG BIOPSY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; REVIEW; TREATMENT OUTCOME;

EID: 0030941424     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70441-X     Document Type: Article

References (88)

1. S.M. Bodner J.D. Minna S.M. Jensen Expression of p53 proteins in lung cancer correlates with the class of p53 gene mutations Oncogene 7 1992 743 749
2. Cancer Facts and Figures–1996 1996 American Cancer Society Atlanta 1 29
3. D. Carbone J. Minna Molecular biology of lung cancer Molecular Foundations of Oncology 1991 339 366
4. N.Z. Carp D.D. Ellison P.F. Brophy DNA content in correlation with postsurgical stage in non–small cell lung cancer Ann Thorac Surg 53 1992 680 683
5. Z. Chen S. Perez E.C. Holmes Frequency and distribution of occult micrometastases in lymph nodes of patients with non–small cell lung carcinoma J Natl Cancer Inst 85 1993 493 498
6. E.S. Cibas M.R. Melamed M.B. Zaman M. Kimmel The effect of tumor size and tumor cell DNA content on the survival of patients with stage I adenocarcinoma of the lung Cancer 63 1989 1552 1556
7. M. Diez A. Torres M. Pollan Prognostic significance of serum CA 125 antigen assay in patients with non–small cell lung cancer Cancer 73 1994 1368 1376
8. C.M. Dresler J.H. Ritter M.R. Wick Immunostains for blood group antigens lack prognostic significance in T1 lung carcinoma Ann Thorac Surg 59 1995 1069 1073
9. D. Eddy Screening for lung cancer Ann Intern Med 111 1989 232 237
10. A.R. Feinstein Symptomatic patterns, biologic behavior, and prognosis in cancer of the lung Ann Intern Med 61 1964 27 43
11. R. Feld Chemotherapy as adjuvant therapy for completely resected non–small cell lung cancer: Have we made progress? J Clin Oncol 14 1996 1045 1047
12. B.J. Flehinger M.R. Melemed Current status of screening for lung cancer Chest Surg Clin North Am 4 1994 1 15
13. B.J. Flehinger M. Kimmel M.R. Melamed The effect of surgical treatment on survival from early lung cancer: Implications for screening Chest 101 1992 1013 1018
14. G. Fontanini S. Vignati D. Bigini Bcl-2 protein: A prognostic factor inversely correlated to p53 in non–small-cell lung cancer Br J Cancer 71 1995 1003 1007
15. M. Fujino H. Dosaka-Akita M. Harada Prognostic significance of p53 and ras p21 expression in nonsmall cell lung cancer Cancer 76 1995 2457 2463
16. M. Gail R.T. Eagan R. Feld Prognostic factors in patients with resected stage I NSCLC: A report from the Lung Cancer Study Group Cancer 54 1984 1802 1813
17. P.A. Hall P.H. McKee H.P. Menage High levels of p53 protein in UV-irradiated normal human skin Oncogene 8 1994 203 207
18. M. Harada H. Dosaka-Akita H. Miyamoto Prognostic significance of the expression of ras oncogene product in non–small cell lung cancer Cancer 69 1992 72 77
19. D.H. Harpole J.E. Herndon W.G. Wolfe A prognostic model of recurrence and death in stage I non–small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression Cancer Res 55 1995 51 56
20. D.H. Harpole J.E. Herndon W.G. Young Stage I non–small cell lung cancer: A multivariate analysis of treatment methods and patterns of recurrence Cancer 76 1995 787 796
21. G. Hillerdal Long-term survival of patients with lung cancer from a defined geographical area before and after radiological screening Lung Cancer 15 1996 21 30
22. Y. Horio T. Takahashi T. Kurosishi Prognostic significance of p53 mutations and 3p deletions in primary resected non–small cell lung cancer Cancer Res 53 1993 1 4
23. E.W. Humphrey Lung cancer Steele G.D. National Cancer Base: Annual Review of Patient Care 1992 American Cancer Society Atlanta 19 28
24. E.W. Humphrey C.R. Smart D.P. Wincester National survey of the pattern of care for carcinoma of the lung Thorac Cardiovasc Surg 100 1990 837 843
25. P. Icard J.F. Regnard A. Essomba Preoperative carcinoembryonic antigen level as a prognostic indicator in resected primary lung cancer Ann Thorac Surg 58 1994 811 814
26. Y. Ichinose N. Hara M. Ohta Is T factor of the TNM staging system a predominant prognostic factor in pathologic stage I non–small-cell lung cancer? J Thorac Cardiovasc Surg 106 1993 90 94
27. S.C. Immerman R.M. Vanecko W.A. Fry Site of recurrence in patients with stages I and II carcinoma of the lung resected for cure Ann Thorac Surg 32 1981 23 27
28. T. Ishida S. Kaneko K. Akazawa Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients Cancer Res 53 1993 5000 5003
29. H.H. Isobe H. Miyamoto T. Shimizu Prognostic and therapeutic significance of the flow cytometric nuclear DNA content in NSCLC Cancer 65 1990 1391 1395
30. neu expression in human lung adenocarcinomas predicts shortened survival Cancer Res 50 1990 5184 5191
31. J.A. Kern R.J.C. Slebos B. Top C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas J Clin Invest 93 1994 516 520
32. A. Kubik J. Polak Lung cancer detection: Results of a randomized prospective study in Czechoslovakia Cancer 57 1986 2428 2437
33. J.J. Lafitte M.E. Ribet B.M. Prevost Postresection irradiation for T2N0M0 non–small cell carcinoma: A prospective, randomized study Ann Thorac Surg 62 1996 830 834
34. D.P. Lane p53, guardian of the genome Nature 358 1992 15 16
35. J.S. Lee A. Yoon S.K. Kalapurakal Expression of p53 oncoprotein in non–small-cell lung cancer: A favorable prognostic factor J Clin Oncol 13 1995 1893 1903
36. J.S. Lee J.Y. Ro A.A. Sahin Expression of blood-group antigen A—a favorable prognostic factor in non–small cell lung cancer N Engl J Med 324 1991 1084 1090
37. J.S. Lee S. Kalapurakal J.Y. Ro W.K. Hong Prognostic significance of retinoblastoma protein expression in non–small cell lung cancer Proc Am Assoc Cancer Res 36 1995 abstract 3787
38. Lipford E.H. III J.C. Eggleston K.D. Lillemoe Prognostic factors in surgically resected limited-stage, nonsmall cell carcinoma of the lung Am J Surg Pathol 8 1984 357 365
39. P. Macchiarini G. Fontanini M.J. Hardin Relation of neovascularisation to metastasis of non–small cell lung cancer Lancet 340 1992 145 146
40. P. Macchiarini G. Fontanini M.J. Hardin Blood vessel invasion by tumor cells predicts recurrence in completely resected T1 N0 M0 non–small cell lung cancer J Thorac Cardiovasc Surg 106 1993 80 89
41. A. Marchetti F. Buttitta G. Merlo p53 alterations in non–small cell lung cancers correlate with metastatic involvement of hilar and mediastinal lymph nodes Cancer Res 53 1993 2846 2851
42. N. Martini M. Burt M. Bains Survival after resection of stage II non–small cell lung cancer Ann Thorac Surg 54 1992 460 466
43. Martini N, Bains MS, Burt ME, et al: Incidence of local recurrence and second primary tumors in resected stage I lung cancer. Proceedings of the American Association for Thoracic Surgery, vol 42, 1994
44. H. Matsumoto H. Muramatsu T. Shimotakahara Correlation of expression of ABH blood group carbohydrate antigens with metastatic potential in human lung carcinomas Cancer 72 1993 75 81
45. R. McLaren I. Kuzu M. Dunnill The relationship of p53 immunostaining to survival in carcinoma of the lung Br J Cancer 66 1992 735 738
46. T. Mitsudomi T. Oyama T. Kusano Mutation of the p53 gene as a predictor of poor prognosis in patients with non–small cell lung cancer J Natl Cancer Inst 85 1993 2018 2023
47. T. Mitsudomi S.M. Steinberg H. Oie Ras gene mutations in non–small cell lung cancers are associated with shortened survival irrespective of treatment intent Cancer Res 51 1991 4999 5002
48. b antigens with survival in patients with carcinoma of the lung N Engl J Med 327 1992 14 18
49. C.F. Mountain A new international staging system for lung cancer Chest 89 1986 225S 233S
50. C.F. Mountain Prognostic implications of the international staging system for lung cancer Semin Oncol 15 1988 236 245
51. T. Naruke T. Goya R. Tsuchiya K. Suemasu Prognosis and survival in resected lung carcinoma based on the new international staging system J Thorac Cardiovasc Surg 96 1988 440 447
52. M. Nishio T. Koshikawa T. Kuroishi Prognostic significance of abnormal p53 accumulation in primary, resected non–small-cell lung cancers J Clin Oncol 14 1996 497 502
53. J. Ogawa A. Sano H. Inoue S. Koide Expression of Lewis-related antigen and prognosis in stage I non–small cell lung cancer Ann Thorac Surg 59 1995 412 415
54. P.C. Pairolero D.E. Williams E.J. Bergstralh Postsurgical stage I bronchogenic carcinoma: Morbid implications of recurrent disease Ann Thorac Surg 38 1984 331 338
55. K. Pantel J. Izbicki B. Passlick Frequency and prognostic significance of isolated tumor cell in bone marrow of patients with non–small cell lung cancer without overt metastases Lancet 347 1996 649 653
56. S.L. Parker T. Tong S. Bolden P.A. Wingo Cancer Statistics–1996 CA Cancer J Clin 46 1996 5 27
57. B. Passlick J.R. Izbicki B. Kubuschak Immunocytochemical assessment of individual tumor cells in lymph nodes of patients with non–small cell lung cancer J Clin Oncol 12 1994 1827 1832
58. J.L. Pater M. Loeb Nonanatomic prognostic factors in carcinoma of the lung: A multivariate analysis Cancer 50 1982 326 331
59. J.C. Pence B.M. Kerns R.K. Dodge J.D. Iglehart Prognostic significance of the proliferation index in surgically-resected non–small cell lung cancer Arch Surg 128 1993 1382 1390
60. F. Pezzella H. Turley I. Kuzu bcl-2 protein in non–small cell lung carcinoma N Engl J Med 329 1993 690 694
61. D.C. Quinlan A.G. Davidson C.L. Summers Accumulation of p53 protein correlates with a poor prognosis in human lung cancer Cancer Res 52 1992 4828 4831
62. S. Rodenhuis R.J. Slebos Clinical significance of ras oncogene activation in human lung cancer Cancer Res 52 suppl 1992 2665s 2669s
63. S. Rodenhuis B. Top The clinical significance of RAS oncogene mutations in non–small cell lung cancer Lung Cancer 11 suppl 2 1994 155 156
64. R. Rosell S. Li Z. Skacel Prognostic impact of mutated K-ras gene in surgically resected non–small cell lung cancer patients Oncogene 8 1993 2407 2412
65. A.A. Sahin J.Y. Ro A.K. El-Naggar Flow cytometric analysis of the DNA content of NSCLC: Ploidy as a significant prognostic indicator in squamous cell carcinoma of the lung Cancer 65 1990 530 537
66. R.A. Schmidt V.W. Rusch S. Piantadosi A flow cytometry study of non–small cell lung cancer classified as T1N0 Cancer 69 1992 78 85
67. D. Shi G. He S. Cao Overexpression of the c-erbB-2/neu-encoded p185 protein in primary lung cancer Molecular Carcinogenesis 5 1992 213 218
68. T.W. Shields Prognostic significance of parenchymal lymphatic vessel and blood vessel invasion in carcinoma of the lung Surg Gynecol Obstet 157 1983 185 190
69. R.J. Slebos R.E. Kibbelaar O. Dalesio K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung N Engl J Med 323 1990 561 565
70. H. Soda H. Tomita S. Kohmo M. Oka Limitation of annual screening radiography for the diagnosis of lung cancer: A retrospective study Cancer 72 1993 2341 2346
71. J.B. Sorensen J.H. Badsberg Prognostic factors in resected stage I and II adenocarcinoma of the lung J Thorac Cardiovasc Surg 99 1990 218 226
72. J.B. Sorensen J.E. Olsen Prognostic implications of histopathologic subtyping in patients with surgically treated stage I or II adenocarcinoma of the lung J Thorac Cardiovasc Surg 97 1989 245 251
73. G.M. Strauss A.T. Skarin Use of tumor markers in lung cancer Hematol Oncol Clin North Am 8 1994 507 532
74. G.M. Strauss R.E. Gleason J.J. Caro D.J. Sugarbaker Screening for lung cancer: Another look; a different view Chest 11 1997 754 768
75. G.M. Strauss D. Kwiatkowski D.H. Harpole Molecular and pathologic markers in stage I non–small cell carcinoma of the lung J Clin Oncol 13 1995 1265 1279
76. D.F. Stern P.A. Heffernan R.A. Weinberg A product of the neu proto-oncogene, is a receptor like protein associated with tyrosine kinase activity, p185 Mol Cell Biol 6 1986 1729 1740
77. N. Sukoh S. Abe S. Ogura Immunohistochemical study of cathepsin B. Prognostic significance in human lung cancer Cancer 74 1994 46 51
78. A. Takise T. Kodama Y. Shimosato Histopathologic prognostic factors in adenocarcinomas of the peripheral lung less than 2 cm in diameter Cancer 61 1988 2083 2088
79. M. Tateishi T. Ishida T. Mitsudomi Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma Eur J Cancer 27 1991 1372 1375
80. Ten Velde G.P. M.G. Havenith A. Volovics Prognostic significance of basement membrane deposition in operable squamous cell carcinomas of the lung Cancer 67 1991 3001 3005
81. P.A. Thomas S. Piantadosi Postoperative T1N0 non–small cell lung cancer: Squamous versus nonsquamous recurrences J Thorac Cardiovasc Surg 94 1987 349 354
82. Van Bodegom P.C. J.P. Baak Stroet-van Galen C. The percentage of aneuploid cells is significantly correlated with survival in accurately staged patients with stage I resected squamous cell lung cancer and long-term follow-up Cancer 63 1989 143 147
83. M. Volm E.W. Hahn J. Mattern Five-year follow-up study of independent clinical and flow cytometric prognostic factors for the survival of patients with non–small cell lung carcinoma Cancer Res 48 1988 2923 2928
84. H.J. Xu D.C. Quinlan A.G. Davidson Altered retinoblastoma protein expression and prognosis in early stage non–small cell lung carcinoma J Natl Cancer Inst 86 1994 695 699
85. T. Yamamoto S. Ikawa T. Akiyama Similarity of protein encoded by the c-erbB-2 gene to epidermal growth factor receptor Nature 319 1986 230 234
86. T. Yano H. Yokoyama T. Inoue Surgical results and prognostic factors of pathologic N1 disease in non–small-cell carcinoma of the lung. Significance of N1 level: Lobar or hilar nodes J Thorac Cardiovasc Surg 107 1994 1398 1402
87. M. Zelen Keynote address on biostatistics and data retrieval Cancer Chemother Rep 4 1973 31 42
88. P.V. Zimmerman M.H. Bint G.A. Hawson P.G. Parsons Ploidy as a prognostic determinant in surgically treated lung cancer Lancet 2 1987 530 533